Technical Analysis for TYP - Tryptamine Therapeutics Limited

Grade Last Price % Change Price Change
B 0.044 10.00% 0.004
TYP closed down 16.67 percent on Tuesday, December 3, 2024, on 1.28 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 10.00%
Wide Range Bar Range Expansion 10.00%
Stochastic Reached Oversold Weakness 10.00%
Wide Bands Range Expansion 10.00%
Gapped Up Strength 10.00%
Oversold Stochastic Weakness 10.00%
Crossed Above 20 DMA Bullish -8.33%
Wide Bands Range Expansion -8.33%
Gapped Up Strength -8.33%
Shooting Star Candlestick Bearish 0.00%

   Recent Intraday Alerts

Alert Time
Gap Up Partially Closed about 1 hour ago
Gapped Up (Partial) about 2 hours ago
10 DMA Resistance about 2 hours ago
Up 5% about 2 hours ago
Up 2% about 2 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development

Is TYP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.057
52 Week Low 0.017
Average Volume 4,229,211
200-Day Moving Average 0.000
50-Day Moving Average 0.031
20-Day Moving Average 0.045
10-Day Moving Average 0.045
Average True Range 0.004
RSI (14) 49.75
ADX 50.08
+DI 28.152
-DI 16.235
Chandelier Exit (Long, 3 ATRs) 0.045
Chandelier Exit (Short, 3 ATRs) 0.042
Upper Bollinger Bands 0.053
Lower Bollinger Band 0.038
Percent B (%b) 0.15
BandWidth 32.743
MACD Line 0.004
MACD Signal Line 0.005
MACD Histogram -0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.055
Resistance 3 (R3) 0.057 0.053 0.053
Resistance 2 (R2) 0.053 0.050 0.053 0.052
Resistance 1 (R1) 0.047 0.047 0.045 0.045 0.051
Pivot Point 0.043 0.043 0.043 0.043 0.043
Support 1 (S1) 0.037 0.040 0.035 0.035 0.029
Support 2 (S2) 0.033 0.037 0.033 0.028
Support 3 (S3) 0.027 0.033 0.028
Support 4 (S4) 0.025